Diane Dahowski - 01 Sep 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Global Supply Chain
Signature: /s/ Diane Dahowski
Issuer symbol: BIO
Transactions as of: 01 Sep 2022
Net transactions value: -$55,432
Form type: 4
Filing time: 06 Sep 2022, 13:50:11 UTC
Previous filing: 06 May 2022
Next filing: 07 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+329	+3.6%	$0.000000	9,351	01 Sep 2022	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$55,432	-114	-1.2%	$486.25	9,237	01 Sep 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+2,082		$0.000000	2,082	01 Sep 2022	Bio-Rad A Common Stock	2,082	$0.000000	Direct	F3, F4
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-329	-25%	$0.000000	988	01 Sep 2022	Bio-Rad A Common Stock	329	$0.000000	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 14.3707 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5	On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.